Know Cancer

or
forgot password
  • cancer clinical trials in birmingham, AL

  • Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia
    Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Non-Small Cell Lung Cancer
    Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Pain, Pancreatic Cancer
    DNA Chip Based Prognosis of Lung Cancer
    University of Alabama
    Birmingham, Alabama
    Carcinoma, Non-Small-Cell Lung
    Investigation of Genetic Determinants of Capecitabine Toxicity
    University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Neurotoxicity
    Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
    University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Lymphoma, Lymphoproliferative Disorder
    A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Non-Hodgkin's Lymphoma
    Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Refractory Cutaneous T-cell Lymphoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Aspirin in Reducing Events in the Elderly
    The University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Functional Disability, Dementia, Heart Disease, Stroke, Cancer, Bleeding
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Adrenocortical Carcinoma, Gastrointestinal Carcinoid Tumor, Kidney Cancer, Neuroblastoma, Retinoblastoma, Sarcoma
    Evaluation of Patients With Bulky GIST Using Sunitinib
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Tumor
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    The Kirklin Clinic at Acton Road
    Birmingham, Alabama 35243
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of Alabama
    Birmingham, Alabama
    Pancreatic Cancer
    A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
    University of Alabama Comprehensive Cancer Center University of Alabama
    Birmingham, Alabama 35294
    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia
    Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Ovarian Mucinous Cystadenocarcinoma, Ovarian Mucinous Cystadenoma With Proliferating Activity, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Stage IA Fallopian Tube Cancer, Stage IA Ovarian Epithelial Cancer, Stage IB Fallopian Tube Cancer, Stage IB Ovarian Epithelial Cancer, Stage IC Fallopian Tube Cancer, Stage IC Ovarian Epithelial Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer
    Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Liver Cancer
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Chronic GVHD
    Reducing Breast Cancer Recurrence With Weight Loss
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer, Overweight, Obesity
    A Phase 1 Study in Participants With Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck, Lung Squamous Cell Carcinoma Stage IV, Anal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung
    EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
    A Multi-center Clinical Trial of the Misago(TM) Self-Expanding Stent System for Superficial Femoral Artery
    University of Alabama
    Birmingham, Alabama
    Peripheral Vascular Disease
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    University of Alabama Hospital
    Birmingham, Alabama 35294
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Kidney Cancer
    Childhood Cancer Survivor Study
    University of Alabama at Birmingham/Children's of Alabama
    Birmingham, Alabama 35294
    Cancer
    First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10013 Boehringer Ingelheim Investigational Site
    Birmingham, Alabama
    Breast Neoplasms
    Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
    University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
    Birmingham, Alabama 35294-0006
    Metastatic Breast Cancer, Trastuzumab, BKM120, HER2+
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Unspecified Childhood Solid Tumor, Protocol Specific
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Childhood Solid Tumor, Protocol Specific
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Carcinoma, Squamous Cell of the Head and Neck